Menu Search

Company Announcements

Merck KGaA

EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition

Source: EQS

EQS-Ad-hoc: Merck KGaA / Key word(s): Takeover
Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition

10-Feb-2025 / 20:06 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Darmstadt, February 10, 2025 – Merck KGaA (“Merck”) reacts to press reports and confirms advanced discussions with Springworks Therapeutics, Inc. Merck also confirms that no legally binding agreement has been entered into. There is no certainty that any transaction will materialize. Furthermore, critical conditions have yet to be met.

End of inside information
 
Contact Merck KGaA
Dr. Gangolf Schrimpf
Merck KGaA
Frankfurter Straße 250
64293 Darmstadt
Germany
Phone: +49 6151 729591
Email: gangolf.schrimpf@merckgroup.com

Internet: https://www.merckgroup.com/

ISIN: DE0006599905
WKN: 659990
Indices: DAX
Stock exchanges: Regulated Market of Frankfurt am Main (Prime Standard); Open Markets of Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart; EUREX derivatives exchange; London, SIX
 


End of Inside Information

10-Feb-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Phone: +49 (0)6151 72 - 2702
E-mail: insiderregister@merckgroup.com
Internet: https://www.merckgroup.com/de
ISIN: DE0006599905
WKN: 659990
Indices: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, SIX
EQS News ID: 2084015

 
End of Announcement EQS News Service

2084015  10-Feb-2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2084015&application_name=news&site_id=acquiremedia~~~1e491ff3-7da4-4be1-bc7b-b8628d89203e